Sign Up to like & get
recommendations!
2
Published in 2023 at "Blood"
DOI: 10.1182/blood.2022019056
Abstract: Acute myeloid leukemia (AML) is an aggressive hematological malignancy. Nearly 50% of patients who receive the most intensive treatment inevitably suffer disease relapse, likely resulting from the persistence of drug‑resistant leukemia stem cells (LSCs). AML…
read more here.
Keywords:
zdhhc21;
palmitoyltransferase;
aml cells;
oxidative phosphorylation ... See more keywords